We have not seen anyone get sick who entered the trial get sick, and this report shows 100% prevention of symptomatic infection among family who took the drug!ġ.27, 2021 Analysis: My Covid-19 vaccine trial experience remains vital as vaccination rates are laggingġ.13, 2021 Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicineġ.21, 2021 Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residentsġ.7, 2021 What’s Happening With Johnson & Johnson’s Covid-19 Vaccine? We have been running this trial for the last several months at Ark Clinical Research, and it is nothing short of amazing results. 29, 2021 Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trialġ.26, 2021 REGENERON REPORTS POSITIVE INTERIM DATA WITH REGEN-COV™ ANTIBODY COCKTAIL USED AS PASSIVE VACCINE TO PREVENT COVID-19 Kim shares his thoughts on a ABC vaccine panel on reaching the Latino community this past week.ġ. Kenneth Kim Weighs in on the COVID-19 VaccinesĢ.5, 2021 Dr. Will We Have to Wear Masks Forever? Innovation Advisor Dr. Because of excellent data with the Regeneron monoclonal antibody study, the 2067 protocol will now be eliminating the placebo arm. Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign. Johnson & Johnson’s single-dose vaccine provides strong shield against severe COVID PHASE 3 TRIAL SHOWS REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB) ANTIBODY COCKTAIL REDUCED HOSPITALIZATION OR DEATH BY 70% IN NON-HOSPITALIZED COVID-19 PATIENTSĪrk is performing these studies and after enrolling hundreds of patients, we can attest to the power of these treatments in preventing severe disease. Was it the placebo or the real thing?Īrk Clinical unblinds CNN reporter participating in the Johnson vaccine trial Vaccine trial participant and CNN correspondent's big reveal. reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a placebo in people living with someone infected by the new coronavirus, a study found.Ĭovid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says - WSJ Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron SaysĪn antibody drug from Regeneron Pharmaceuticals Inc. Ark specializes in outpatient clinical trials and it has been assisting COVID-19 vaccine and treatment trials during the most important time. Consistently keeping its patients' well-being as top priority, Ark is dedicated to introducing innovative therapeutic regimens, treatments, devices, and delivery methods. Ark’s primary objective is to improve each patient's quality of life through the development of more effective therapies and devices. Kenneth Kim, on selection as the 37th Senatorial District’s 2021 Small Business of the Year, commends it for providing valuable services to the people of the local area and contributing to the growth of California’s economy, and applauds its history of community support.Īrk Clinical Research is multi-therapeutic clinical research site located in Long Beach and Tustin, CA. “Resolved by Senator Dave Min, that he takes immense pleasure in congratulating Ark Clinical Research and its founder, Dr. Ark Clinical Research was selected as one of the 75 small businesses being recognized in California and received the “Small Business of the Year” award on August 18th, 2021.